The consolidated net sales for the first quarter of FY2027 are JPY 15,088 million, an increase of 9.6% YoY. Operating profit is JPY 2,805 million, and net profit is JPY 6,691 million, both showing increases. Segments such as arrhythmia and ischemia business are performing well.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3079","jir_company_name":"DeepX Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-07-31","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/3079-20260731-01.pdf","jir_short_summary":"The consolidated net sales for the first quarter of FY2027 are JPY 15,088 million, an increase of 9.6% YoY. Operating profit is JPY 2,805 million, and net profit is JPY 6,691 million, both showing increases. Segments such as arrhythmia and ischemia business are performing well.","jir_summary":"### Performance Overview\nDeepX's consolidated financial results for the first quarter of FY2027 show net sales of JPY 15,088 million (+9.6% YoY), operating profit of JPY 2,805 million (+23.1% YoY), and net profit of JPY 6,691 million (+162.0% YoY), representing significant growth. The positive performance was driven mainly by strong results in the arrhythmia and ischemia businesses, with improvements in cost management and contributions from new products also boosting profitability.\n\n### Outlook and Impact on Investors\nFuture growth is expected through the continued launch of new products and market expansion, with ongoing increases in sales and profits. Particular attention is on the growth of the ischemia segment, which is anticipated to strengthen the overall revenue foundation. For investors, strong performance and growth strategies are likely to enhance stock value.","jir_financial_highlights":"Net Sales: JPY 15,088 million (YoY +9.6%)\nOperating Profit: JPY 2,805 million (YoY +23.1%)\nNet Profit: JPY 6,691 million (YoY +162.0%)","jir_category":"","jir_hashtags":"#DeepX, #IRResults, #JapaneseStocks","jir_key_figures":"Net Sales: JPY 15,088 million (YoY +9.6%)\nOperating Profit: JPY 2,805 million (YoY +23.1%)\nNet Profit: JPY 6,691 million (YoY +162.0%)","jir_meta_title":"\u3010DeepX\u3011FY2027 Q1 Results\uff5cNet Sales JPY 15,088 million (+9.6%)","jir_meta_description":"DeepX's FY2027 Q1 financial results show net sales of JPY 15,088 million and net profit of JPY 6,691 million, with significant profit growth. Growth expectations remain high.","jir_og_title":"\u3010DeepX\u3011FY2027 Q1 Results\uff5cNet Sales JPY 15,088 million","jir_og_description":"Latest financial results of DeepX. Maintains rising sales and high profitability, fueling growth expectations.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q4 FY2026\\\",\\\"Q1 FY2027\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[13766,856,15088],\\\"fill\\\":false,\\\"borderColor\\\":\\\"#36A2EB\\\"}]}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Profit Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q4 FY2026\\\",\\\"Q1 FY2027\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Profit\\\",\\\"data\\\":[2278,398,2805],\\\"fill\\\":false,\\\"borderColor\\\":\\\"#4BC0C0\\\"}]}}\"}, {\"jir_chart_id\": \"net_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Profit Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q4 FY2026\\\",\\\"Q1 FY2027\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Profit\\\",\\\"data\\\":[6691,0,0,6691],\\\"fill\\\":false,\\\"borderColor\\\":\\\"#FF6384\\\"}]}}\"}]","ir_related_company":58587,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-92299","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n